在肺腺癌中,TNFRSF21的丧失会诱导思普拉丁敏感性

Daien Zhou1, Haoyang Yuan2, Yiwei Hu3

  • 1Department of Thoracic Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, The Second People's Hospital of Huai'an, Huai'an, 223001, China.

Oncology research
|March 20, 2025
PubMed
概括

瘤坏死因子受体超级家族成员21 (TNFRSF21) 在肺腺癌 (LUAD) 中被上调,促进瘤细胞的增殖和耐药性. 下调TNFRSF21可能为肺癌化疗提供一个新的策略,特别是针对癌症干细胞 (CSCs).